| Stephen H Hand, MD | |
|
2000 East Greenville St, Suite 1100, Anderson, SC 29621-1714 | |
| (864) 225-5667 | |
| (864) 716-6746 |
| Full Name | Stephen H Hand |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 41 Years |
| Location | 2000 East Greenville St, Anderson, South Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144225566 | NPI | - | NPPES |
| P0044910 | Other | SC | RR MEDICARE |
| 8607 | Other | SC | MEIDCARE GROUP NUMBER |
| 000477265C | Medicaid | GA | |
| 124172 | Medicaid | SC |
| Facility Name | Location | Facility Type |
|---|---|---|
| Anmed Health | Anderson, SC | Hospital |
| Cannon Memorial Hospital | Pickens, SC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Anmed Health | 1951215243 | 276 |
News Archive
Scientists at the Centre for Genomic Regulation in Barcelona, Spain, have joined today the Global City Sampling Day for the MetaSub research project. Started in 2013 in New York and led by Dr. Christopher E Mason at Weill Cornell Medicine, MetaSub is an international consortium of laboratories to establish a world-wide "DNA map" of microbiomes in mass transit systems.
Diakron Pharmaceuticals, Inc. announced today the signing of an exclusive license agreement for a novel investigational oral anticoagulant drug candidate discovered and developed through Phase I clinical trials by Merck & Co. Inc. Under the terms of the agreement, Diakron has the exclusive rights to develop, and, if approved, market and distribute the compound worldwide.
A substantial proportion of Americans have prehypertension (blood pressure above optimal levels, but not clinical hypertension) which is associated with an increased prevalence of other risk factors for heart disease and stroke and is also associated with potential increased risk for hospitalization and death
SI-BONE, Inc., a medical device company that pioneered the use of the iFuse Implant System, a minimally invasive surgical (MIS) device indicated for fusion for certain disorders of the sacroiliac (SI) joint, won the Gold 2014 International MarCom Award for its SI Joint Patient Community website and an Honorable Mention for the SI Buddy Patient Networking Program.
› Verified 9 days ago
| Entity Name | Anmed Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710918321 PECOS PAC ID: 1951215243 Enrollment ID: O20031119000738 |
News Archive
Scientists at the Centre for Genomic Regulation in Barcelona, Spain, have joined today the Global City Sampling Day for the MetaSub research project. Started in 2013 in New York and led by Dr. Christopher E Mason at Weill Cornell Medicine, MetaSub is an international consortium of laboratories to establish a world-wide "DNA map" of microbiomes in mass transit systems.
Diakron Pharmaceuticals, Inc. announced today the signing of an exclusive license agreement for a novel investigational oral anticoagulant drug candidate discovered and developed through Phase I clinical trials by Merck & Co. Inc. Under the terms of the agreement, Diakron has the exclusive rights to develop, and, if approved, market and distribute the compound worldwide.
A substantial proportion of Americans have prehypertension (blood pressure above optimal levels, but not clinical hypertension) which is associated with an increased prevalence of other risk factors for heart disease and stroke and is also associated with potential increased risk for hospitalization and death
SI-BONE, Inc., a medical device company that pioneered the use of the iFuse Implant System, a minimally invasive surgical (MIS) device indicated for fusion for certain disorders of the sacroiliac (SI) joint, won the Gold 2014 International MarCom Award for its SI Joint Patient Community website and an Honorable Mention for the SI Buddy Patient Networking Program.
› Verified 9 days ago
| Entity Name | Anmed Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639102270 PECOS PAC ID: 1951215243 Enrollment ID: O20040130000302 |
News Archive
Scientists at the Centre for Genomic Regulation in Barcelona, Spain, have joined today the Global City Sampling Day for the MetaSub research project. Started in 2013 in New York and led by Dr. Christopher E Mason at Weill Cornell Medicine, MetaSub is an international consortium of laboratories to establish a world-wide "DNA map" of microbiomes in mass transit systems.
Diakron Pharmaceuticals, Inc. announced today the signing of an exclusive license agreement for a novel investigational oral anticoagulant drug candidate discovered and developed through Phase I clinical trials by Merck & Co. Inc. Under the terms of the agreement, Diakron has the exclusive rights to develop, and, if approved, market and distribute the compound worldwide.
A substantial proportion of Americans have prehypertension (blood pressure above optimal levels, but not clinical hypertension) which is associated with an increased prevalence of other risk factors for heart disease and stroke and is also associated with potential increased risk for hospitalization and death
SI-BONE, Inc., a medical device company that pioneered the use of the iFuse Implant System, a minimally invasive surgical (MIS) device indicated for fusion for certain disorders of the sacroiliac (SI) joint, won the Gold 2014 International MarCom Award for its SI Joint Patient Community website and an Honorable Mention for the SI Buddy Patient Networking Program.
› Verified 9 days ago
| Entity Name | Anmed Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427005727 PECOS PAC ID: 1951215243 Enrollment ID: O20040723000885 |
News Archive
Scientists at the Centre for Genomic Regulation in Barcelona, Spain, have joined today the Global City Sampling Day for the MetaSub research project. Started in 2013 in New York and led by Dr. Christopher E Mason at Weill Cornell Medicine, MetaSub is an international consortium of laboratories to establish a world-wide "DNA map" of microbiomes in mass transit systems.
Diakron Pharmaceuticals, Inc. announced today the signing of an exclusive license agreement for a novel investigational oral anticoagulant drug candidate discovered and developed through Phase I clinical trials by Merck & Co. Inc. Under the terms of the agreement, Diakron has the exclusive rights to develop, and, if approved, market and distribute the compound worldwide.
A substantial proportion of Americans have prehypertension (blood pressure above optimal levels, but not clinical hypertension) which is associated with an increased prevalence of other risk factors for heart disease and stroke and is also associated with potential increased risk for hospitalization and death
SI-BONE, Inc., a medical device company that pioneered the use of the iFuse Implant System, a minimally invasive surgical (MIS) device indicated for fusion for certain disorders of the sacroiliac (SI) joint, won the Gold 2014 International MarCom Award for its SI Joint Patient Community website and an Honorable Mention for the SI Buddy Patient Networking Program.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Stephen H Hand, MD 2000 East Greenville St, Suite 1100, Anderson, SC 29621-1714 Ph: (864) 225-5667 | Stephen H Hand, MD 2000 East Greenville St, Suite 1100, Anderson, SC 29621-1714 Ph: (864) 225-5667 |
News Archive
Scientists at the Centre for Genomic Regulation in Barcelona, Spain, have joined today the Global City Sampling Day for the MetaSub research project. Started in 2013 in New York and led by Dr. Christopher E Mason at Weill Cornell Medicine, MetaSub is an international consortium of laboratories to establish a world-wide "DNA map" of microbiomes in mass transit systems.
Diakron Pharmaceuticals, Inc. announced today the signing of an exclusive license agreement for a novel investigational oral anticoagulant drug candidate discovered and developed through Phase I clinical trials by Merck & Co. Inc. Under the terms of the agreement, Diakron has the exclusive rights to develop, and, if approved, market and distribute the compound worldwide.
A substantial proportion of Americans have prehypertension (blood pressure above optimal levels, but not clinical hypertension) which is associated with an increased prevalence of other risk factors for heart disease and stroke and is also associated with potential increased risk for hospitalization and death
SI-BONE, Inc., a medical device company that pioneered the use of the iFuse Implant System, a minimally invasive surgical (MIS) device indicated for fusion for certain disorders of the sacroiliac (SI) joint, won the Gold 2014 International MarCom Award for its SI Joint Patient Community website and an Honorable Mention for the SI Buddy Patient Networking Program.
› Verified 9 days ago
Shahzad H Sheikh, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 118 Montgomery Dr, Anderson, SC 29621 Phone: 864-512-5849 Fax: 864-512-7575 | |
Winston Cordell Floyd, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 400 North Fant Street, Suite G, Anderson, SC 29621 Phone: 864-224-2197 Fax: 864-225-0033 | |
David W Potts, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 118 Montgomery Dr, Anderson, SC 29621 Phone: 864-512-3915 Fax: 864-260-3920 | |
Sanjeev Kumar, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 819 N Fant St, Anderson, SC 29621 Phone: 864-261-1800 Fax: 864-261-1856 | |
Rajeev Malik, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 2000 E Greenville St, Ste 5000, Anderson, SC 29621 Phone: 864-224-5765 Fax: 864-224-1449 | |
Daniel W. Grisham Sr., M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2000 E Greenville St Ste 2300, Anderson, SC 29621 Phone: 864-512-5780 Fax: 864-375-1155 | |
Dr. William Muirhead Turner, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 131 Addis Cir, Anderson, SC 29626 Phone: 864-934-6833 |